3,5-Diethoxybenzaldehyde → N-[1-(3,5-Diethoxy-benzyl)piperidin-4-yl]-5-methyl-nicotinamide
Reaction equation
[CH3:1][C:2]1[CH:3]=[N:4][CH:5]=[C:6]([CH:16]=1)[C:7]([NH:9][CH:10]1[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1)=[O:8].[CH2:17]([O:19][C:20]1[CH:21]=[C:22]([CH:25]=[C:26]([O:28][CH2:29][CH3:30])[CH:27]=1)[CH:23]=O)[CH3:18]>>[CH2:29]([O:28][C:26]1[CH:25]=[C:22]([CH:21]=[C:20]([O:19][CH2:17][CH3:18])[CH:27]=1)[CH2:23][N:13]1[CH2:12][CH2:11][CH:10]([NH:9][C:7](=[O:8])[C:6]2[CH:16]=[C:2]([CH3:1])[CH:3]=[N:4][CH:5]=2)[CH2:15][CH2:14]1)[CH3:30]Participants
3
Procedure
The title compound (13 mg, 33%) was prepared analogously to example 30 from 5-methyl-N-(piperidin-4-yl)-nicotinamide and 3,5-diethoxybenzaldehyde. MS: 398.5 (MH+).
Sources & evidence
- ORD record
- ord-9650ad86a9c7453db7098246fd793bc6
- Source dataset
- uspto-grants-2010_08
- Patent number
- US07772253B2
Reaction notes
Loading…